Glaukos GKOS
NYSE GKOS
$176.04 +2.61 (+1.50%)
As of: Oct 21, 2026 · 11:40 AM EDT

Glaukos (GKOS) EV to EBITDA (2016 - 2022)

Updated

Glaukos' (GKOS) EV to EBITDA was 95.45 for Q2 2022, down 88.4% from 822.83 a year earlier but up 58.8% from the prior quarter.

Analysis

Glaukos (GKOS) EV to EBITDA (2016 - 2022) Analysis & Trends

Over the twelve months ended Jun 30, 2022, Glaukos' EV to EBITDA came in at 80.56, down 89.5% year-over-year; for FY2021, it was 91.54.

  • By year, EV to EBITDA came in at 269.75 in FY2017 (+108.8%).
  • Five-year quarterly EV to EBITDA spans a low of 60.11 in Q1 2022 and a high of 822.83 in Q2 2021.
  • Per Business Quant data, the three quarters before Q2 2022 came in at 60.11 (Q1 2022), 91.54 (Q4 2021) and 76.38 (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 260.30 Bn 239.33 Bn 4.88 Bn
2 Abbott Laboratories 170.90 Bn 141.33 Bn 7.27 Bn
3 Danaher 164.81 Bn 148.62 Bn 3.61 Bn
4 Intuitive Surgical 152.46 Bn 131.89 Bn 1.96 Bn
5 Medtronic 119.28 Bn 84.53 Bn 6.34 Bn
6 Stryker 112.91 Bn 99.03 Bn 4.50 Bn
7 Boston Scientific 64.87 Bn 59.63 Bn 3.85 Bn
8 Becton Dickinson 53.24 Bn 50.39 Bn 2.32 Bn
9 Edwards Lifesciences 50.42 Bn 34.43 Bn 1.35 Bn
10 Glaukos 10.38 Bn 9.97 Bn 151.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 89.72
Mar 31, 2022 58.27
Dec 31, 2021 86.09
Sep 30, 2021 68.11
Jun 30, 2021 368.12
Dec 31, 2017 268.07
Sep 30, 2017 378.32
Jun 30, 2017 489.47
Mar 31, 2017 204.43
Dec 31, 2016 129.17
Sep 30, 2016 200.46
Jun 30, 2016 279.36
API Access

Glaukos EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GKOS&period=max&api_key=YOUR_API_KEY